You can:
Name | Galanin receptor type 3 |
---|---|
Species | Homo sapiens (Human) |
Gene | GALR3 |
Synonym | GAL3-R Galnr3 GALR-3 GALR3 GAL3 receptor |
Disease | Cognitive disorders |
Length | 368 |
Amino acid sequence | MADAQNISLDSPGSVGAVAVPVVFALIFLLGTVGNGLVLAVLLQPGPSAWQEPGSTTDLFILNLAVADLCFILCCVPFQATIYTLDAWLFGALVCKAVHLLIYLTMYASSFTLAAVSVDRYLAVRHPLRSRALRTPRNARAAVGLVWLLAALFSAPYLSYYGTVRYGALELCVPAWEDARRRALDVATFAAGYLLPVAVVSLAYGRTLRFLWAAVGPAGAAAAEARRRATGRAGRAMLAVAALYALCWGPHHALILCFWYGRFAFSPATYACRLASHCLAYANSCLNPLVYALASRHFRARFRRLWPCGRRRRHRARRALRRVRPASSGPPGCPGDARPSGRLLAGGGQGPEPREGPVHGGEAARGPE |
UniProt | O60755 |
Protein Data Bank | N/A |
GPCR-HGmod model | O60755 |
3D structure model | This predicted structure model is from GPCR-EXP O60755. |
BioLiP | N/A |
Therapeutic Target Database | T98494 |
ChEMBL | CHEMBL2731 |
IUPHAR | 245 |
DrugBank | N/A |
Name | MLS000998903 |
---|---|
Molecular formula | C21H30FN3OS |
IUPAC name | 2-[1-(2,2-dimethylpropyl)-4-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl]piperazin-2-yl]ethanol |
Molecular weight | 391.549 |
Hydrogen bond acceptor | 6 |
Hydrogen bond donor | 1 |
XlogP | 3.9 |
Synonyms | 2-(1-(2,2-dimethylpropyl)-4-{[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl}-2-piperazinyl)ethanol CHEMBL1720771 SR-01000171970-1 2-[1-(2,2-dimethylpropyl)-4-[[4-(4-fluorophenyl)-2-thiazolyl]methyl]-2-piperazinyl]ethanol MCULE-9026269767 [ Show all ] |
Inchi Key | GOUYUKOYEGKQEP-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C21H30FN3OS/c1-21(2,3)15-25-10-9-24(12-18(25)8-11-26)13-20-23-19(14-27-20)16-4-6-17(22)7-5-16/h4-7,14,18,26H,8-13,15H2,1-3H3 |
PubChem CID | 23723905 |
ChEMBL | CHEMBL1720771 |
IUPHAR | N/A |
BindingDB | 97134 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 2829.0 nM | , PubChem BioAssay data set | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417